An oral therapy for the prevention and treatment of malaria. POP: 09/16/2020 to 03/15/2021.
Ended Awarded Last action
- Contract number
- 75N95020F00001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $438,950
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR17200218 · Posted Apr 7, 2020
- Contract value 100% obligated
- $438,950.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $6,514 | |
| Funding Only Action | -$6,685 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $124,406 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $314,715 |
About this award
The National Institute on Drug Abuse issued a delivery order to Sri International on September 16, 2020, under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" parent IDIQ with a ceiling value of $438,950.44. The order covers an oral therapy for the prevention and treatment of malaria, with performance spanning September 16, 2020 through July 23, 2021.
Place of performance is Menlo Park, CA. The order is priced on a cost-plus-fixed-fee basis with no set-aside applied.
During FY2021, the order generated $374 thousand in invoiced revenue across 0.9 FTEs and 1,807 contractor hours, at a derived government-paid hourly rate of $207.26/hr. Sri International self-performed all reported labor with no subcontractor engagement on this effort.
Quick answers
Who was awarded contract 75N95020F00001?
75N95020F00001 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 16, 2020.
How much is contract 75N95020F00001 worth?
The government has obligated $438,950 on 75N95020F00001.
Is contract 75N95020F00001 an order under another contract?
Yes. 75N95020F00001 is a delivery order under HHSN271201700014I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95020F00001 competed?
The extent of competition for 75N95020F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award